203 related articles for article (PubMed ID: 25230231)
1. Quinoline derivatives: candidate drugs for a class B G-protein coupled receptor, the calcitonin gene-related peptide receptor, a cause of migraines.
Iftikhar H; Ahmad I; Gan SH; Shaik MM; Iftikhar N; Nawaz MS; Greig NH; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(7):1130-9. PubMed ID: 25230231
[TBL] [Abstract][Full Text] [Related]
2. CGRP and its receptors.
Hay DL; Walker CS
Headache; 2017 Apr; 57(4):625-636. PubMed ID: 28233915
[TBL] [Abstract][Full Text] [Related]
3. New Insights into the Regulation of CGRP-Family Receptors.
Gingell JJ; Hendrikse ER; Hay DL
Trends Pharmacol Sci; 2019 Jan; 40(1):71-83. PubMed ID: 30527443
[TBL] [Abstract][Full Text] [Related]
4. Are antimigraine drugs that influence CGRP levels justified?
Piechal A; Domitrz I; Kurkowska-Jastrzębska I; Mirowska-Guzel D
Pharmacol Rep; 2019 Aug; 71(4):624-635. PubMed ID: 31181379
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
Hargreaves R; Olesen J
Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
[TBL] [Abstract][Full Text] [Related]
6. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
7. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.
Moore EL; Salvatore CA
Br J Pharmacol; 2012 May; 166(1):66-78. PubMed ID: 21871019
[TBL] [Abstract][Full Text] [Related]
8. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
[TBL] [Abstract][Full Text] [Related]
9. To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor (CGRPR) Using Molecular Dynamics Simulations.
Leung L; Liao S; Wu C
ACS Chem Neurosci; 2021 Jul; 12(14):2629-2642. PubMed ID: 34184869
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin Gene-Related Peptide Antagonists and Therapeutic Antibodies.
Rujan RM; Reynolds CA
Handb Exp Pharmacol; 2019; 255():169-192. PubMed ID: 30689083
[TBL] [Abstract][Full Text] [Related]
11. CGRP Antagonists for the Treatment of Chronic Migraines: a Comprehensive Review.
Urits I; Jones MR; Gress K; Charipova K; Fiocchi J; Kaye AD; Viswanath O
Curr Pain Headache Rep; 2019 Mar; 23(5):29. PubMed ID: 30874961
[TBL] [Abstract][Full Text] [Related]
12. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
13. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
Edvinsson L; Warfvinge K
Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
[TBL] [Abstract][Full Text] [Related]
14. Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.
Edvinsson L
Expert Opin Ther Targets; 2007 Sep; 11(9):1179-88. PubMed ID: 17845144
[TBL] [Abstract][Full Text] [Related]
15. Pain pharmacology in migraine: focus on CGRP and CGRP receptors.
Benemei S; Nicoletti P; Capone JA; Geppetti P
Neurol Sci; 2007 May; 28 Suppl 2():S89-93. PubMed ID: 17508187
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.
Eftekhari S; Warfvinge K; Blixt FW; Edvinsson L
J Pain; 2013 Nov; 14(11):1289-303. PubMed ID: 23958278
[TBL] [Abstract][Full Text] [Related]
18. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin gene-related peptide: an update on the biology.
Recober A; Russo AF
Curr Opin Neurol; 2009 Jun; 22(3):241-6. PubMed ID: 19434786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
